Back to Feed
ClinicalTrials.gov|Clinical Trial
An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma
Guangzhou FineImmune Biotechnology Co., LTD.
Abstract
This study was a phase I safety and tolerability clinical trial conducted in a single-center, open-label, 3+3 design with dose escalation. Phase: PHASE1 Status: RECRUITING Conditions: Advanced Hepatocellular Carcinoma (HCC); GPC3 Positive Hepatocellular Carcinoma Interventions: Super CAR-T
Keywords
Advanced Hepatocellular Carcinoma (HCC)GPC3 Positive Hepatocellular Carcinoma